Summary
64.73 0.37(0.57%)05/10/2024
Globus Medical Inc (GMED)
Globus Medical Inc (GMED)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| 2.45 | 3.42 | -3.14 | -2.55 | 11.49 | -11.47 | -98.63 | -99.93 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 51.50 | |
| Open | 50.56 | |
| High | 51.86 | |
| Low | 50.47 | |
| Volume | 623,025 | |
| Change | 1.23 | |
| Change % | 2.45 | |
| Avg Volume (20 Days) | 721,514 | |
| Volume/Avg Volume (20 Days) Ratio | 0.86 | |
| 52 Week Range | 43.39 - 62.88 | |
| Price vs 52 Week High | -18.11% | |
| Price vs 52 Week Low | 18.68% | |
| Range | 1.85 | |
| Gap Up/Down | -1.98 | |
Fundamentals | ||
| Market Capitalization (Mln) | 8,741 | |
| EBIDTA | 299,223,008 | |
| PE Ratio | 37.3968 | |
| PEG Ratio | 2.7087 | |
| WallStreet Target Price | 87.50 | |
| Book Value | 16.9350 | |
| Earnings Per Share | 1.8170 | |
| EPS Estimate Current Quarter | 0.4500 | |
| EPS Estimate Next Quarter | 0.5000 | |
| EPS Estimate Current Year | 2.0200 | |
| EPS Estimate Next Year | 2.2300 | |
| Diluted EPS (TTM) | 1.8170 | |
| Revenues | ||
| Profit Marging | 0.1987 | |
| Operating Marging (TTM) | 0.2435 | |
| Return on asset (TTM) | 0.0830 | |
| Return on equity (TTM) | 0.1193 | |
| Revenue TTM | 941,526,016 | |
| Revenue per share TTM | 9.4060 | |
| Quarterly Revenue Growth (YOY) | 0.0630 | |
| Quarterly Earnings Growth (YOY) | 0.0230 | |
| Gross Profit (TTM) | 571,579,000 | |
| Dividends | ||
| Dividend Share | 0.0000 | |
| Dividend Yield | ||
| Valuations | ||
| Trailing PE | 37.3968 | |
| Forward PE | 29.7619 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 4.0127 | |
| Revenue Enterprise Value | 6.7348 | |
| EBITDA Enterprise Value | 21.1915 | |
| Shares | ||
| Shares Outstanding | 79,029,600 | |
| Shares Float | 76,592,207 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.00 | |
| Insider (%) | 0.85 | |
| Institutions (%) | 70.30 | |
05/09 12:41 EST - Zacks Investment Research
GMED or PEN: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Instruments stocks are likely familiar with Globus Medical (GMED) and Penumbra (PEN). But which of these two stocks presents investors with the better value opportunity right now?
GMED or PEN: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Instruments stocks are likely familiar with Globus Medical (GMED) and Penumbra (PEN). But which of these two stocks presents investors with the better value opportunity right now?
05/09 10:16 EST - Zacks Investment Research
Globus Medical, Inc. (GMED) Hit a 52 Week High, Can the Run Continue?
Globus Medical (GMED) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Globus Medical, Inc. (GMED) Hit a 52 Week High, Can the Run Continue?
Globus Medical (GMED) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
05/08 10:46 EST - Zacks Investment Research
Why Globus Medical (GMED) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Globus Medical (GMED) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
05/08 09:56 EST - Zacks Investment Research
Globus Medical (GMED) Q1 Earnings Top Estimates, Margins Fall
Globus Medical (GMED) delivers massive sales and earnings growth in the first quarter of 2024.
Globus Medical (GMED) Q1 Earnings Top Estimates, Margins Fall
Globus Medical (GMED) delivers massive sales and earnings growth in the first quarter of 2024.
05/07 23:24 EST - Seeking Alpha
Globus Medical, Inc. (GMED) Q1 2024 Earnings Call Transcript
Globus Medical, Inc. (NYSE:GMED ) Q1 2024 Earnings Conference Call May 7, 2024 4:30 PM ET Company Participants Brian Kearns - Senior Vice President, Business Development and Investor Relations Daniel Scavilla - President and Chief Executive Officer Keith Pfeil - Chief Operating Officer and Chief Financial Officer Conference Call Participants Matt Blackman - Stifel Matt Taylor - Jefferies Ryan Zimmerman - BTIG Steve Lichtman - Oppenheimer & Company Craig Bijou - Bank of America Securities Caitlin Cronin - Canaccord Genuity Ravi Mishra - Truist Securities Operator Thank you for standing by. Welcome to the Globus Medical First Quarter 2024 Earnings Call.
Globus Medical, Inc. (GMED) Q1 2024 Earnings Call Transcript
Globus Medical, Inc. (NYSE:GMED ) Q1 2024 Earnings Conference Call May 7, 2024 4:30 PM ET Company Participants Brian Kearns - Senior Vice President, Business Development and Investor Relations Daniel Scavilla - President and Chief Executive Officer Keith Pfeil - Chief Operating Officer and Chief Financial Officer Conference Call Participants Matt Blackman - Stifel Matt Taylor - Jefferies Ryan Zimmerman - BTIG Steve Lichtman - Oppenheimer & Company Craig Bijou - Bank of America Securities Caitlin Cronin - Canaccord Genuity Ravi Mishra - Truist Securities Operator Thank you for standing by. Welcome to the Globus Medical First Quarter 2024 Earnings Call.
05/07 19:01 EST - Zacks Investment Research
Globus Medical (GMED) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Globus Medical (GMED) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Globus Medical (GMED) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Globus Medical (GMED) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
05/07 18:31 EST - Zacks Investment Research
Globus Medical (GMED) Q1 Earnings and Revenues Beat Estimates
Globus Medical (GMED) came out with quarterly earnings of $0.72 per share, beating the Zacks Consensus Estimate of $0.55 per share. This compares to earnings of $0.53 per share a year ago.
Globus Medical (GMED) Q1 Earnings and Revenues Beat Estimates
Globus Medical (GMED) came out with quarterly earnings of $0.72 per share, beating the Zacks Consensus Estimate of $0.55 per share. This compares to earnings of $0.53 per share a year ago.
05/06 10:22 EST - Zacks Investment Research
Wall Street's Insights Into Key Metrics Ahead of Globus Medical (GMED) Q1 Earnings
Evaluate the expected performance of Globus Medical (GMED) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Wall Street's Insights Into Key Metrics Ahead of Globus Medical (GMED) Q1 Earnings
Evaluate the expected performance of Globus Medical (GMED) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
04/23 12:41 EST - Zacks Investment Research
GMED vs. PEN: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Instruments stocks have likely encountered both Globus Medical (GMED) and Penumbra (PEN). But which of these two companies is the best option for those looking for undervalued stocks?
GMED vs. PEN: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Instruments stocks have likely encountered both Globus Medical (GMED) and Penumbra (PEN). But which of these two companies is the best option for those looking for undervalued stocks?
04/16 16:30 EST - GlobeNewsWire
Globus Medical Schedules First Quarter Earnings Release and Conference Call
AUDUBON, Pa., April 16, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31, 2024 after the market close on Tuesday, May 7, 2024. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com.
Globus Medical Schedules First Quarter Earnings Release and Conference Call
AUDUBON, Pa., April 16, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31, 2024 after the market close on Tuesday, May 7, 2024. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com.
04/15 10:51 EST - Zacks Investment Research
Why Globus Medical (GMED) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Globus Medical (GMED) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
04/04 09:47 EST - Zacks Investment Research
Globus Medical (GMED) Gains From New Launches Amid Macro Issues
Globus Medical (GMED) witnesses notable gains across its product portfolio in expandables, biologics, MIS screws, 3D printed implants and cervical offerings.
Globus Medical (GMED) Gains From New Launches Amid Macro Issues
Globus Medical (GMED) witnesses notable gains across its product portfolio in expandables, biologics, MIS screws, 3D printed implants and cervical offerings.
03/24 15:50 EST - InvestorPlace
From Six Figures to Seven: 3 Robotics Stocks Set to Make Millionaires
One of the riskier but incredibly compelling opportunities, robotics stocks could be poised to mint new millionaires. It all comes down to the projected numbers.
From Six Figures to Seven: 3 Robotics Stocks Set to Make Millionaires
One of the riskier but incredibly compelling opportunities, robotics stocks could be poised to mint new millionaires. It all comes down to the projected numbers.
03/13 16:30 EST - InvestorPlace
7 Robotic Surgery Stocks to Buy for the Future of Healthcare
There are some robotic surgery stocks for investors to buy in March this year. The growth of robotic-assisted surgery has been driven by its potential benefits, such as smaller incisions, reduced pain and scarring, quicker recovery times, and improved clinical outcomes.
7 Robotic Surgery Stocks to Buy for the Future of Healthcare
There are some robotic surgery stocks for investors to buy in March this year. The growth of robotic-assisted surgery has been driven by its potential benefits, such as smaller incisions, reduced pain and scarring, quicker recovery times, and improved clinical outcomes.
03/13 13:06 EST - Zacks Investment Research
Here's Why You Should Retain Globus Medical (GMED) Stock Now
Investors are optimistic about Globus Medical (GMED), led by growth in the U.S. spine business and progress in the recently merged NuVasive business.
Here's Why You Should Retain Globus Medical (GMED) Stock Now
Investors are optimistic about Globus Medical (GMED), led by growth in the U.S. spine business and progress in the recently merged NuVasive business.
02/27 10:46 EST - Zacks Investment Research
Here's Why Globus Medical (GMED) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Globus Medical (GMED) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
02/26 10:56 EST - Zacks Investment Research
Here's Why Globus Medical (GMED) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Globus Medical (GMED) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
02/21 08:16 EST - Zacks Investment Research
Globus Medical (GMED) Q4 Earnings Surpass, Margins Down
Globus Medical's (GMED) fourth-quarter 2023 performance benefits from innovative launches across its product groups.
Globus Medical (GMED) Q4 Earnings Surpass, Margins Down
Globus Medical's (GMED) fourth-quarter 2023 performance benefits from innovative launches across its product groups.
02/20 23:01 EST - Seeking Alpha
Globus Medical, Inc. (GMED) Q4 2023 Earnings Call Transcript
Globus Medical, Inc. (GMED) Q4 2023 Earnings Call Transcript
Globus Medical, Inc. (GMED) Q4 2023 Earnings Call Transcript
Globus Medical, Inc. (GMED) Q4 2023 Earnings Call Transcript
02/20 20:01 EST - Zacks Investment Research
Compared to Estimates, Globus Medical (GMED) Q4 Earnings: A Look at Key Metrics
The headline numbers for Globus Medical (GMED) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Compared to Estimates, Globus Medical (GMED) Q4 Earnings: A Look at Key Metrics
The headline numbers for Globus Medical (GMED) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.